OncoGenex Pharmaceuticals (OGXI) Earnings
|
Expand Research on OGXI
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +22.6% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +1.1% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/10/16 | Q316 | -$0.12 | -$0.26 | +$0.14 | N/A | N/A | N/A | Details | |||
8/4/16 | Q216 | -$0.23 | -$0.22 | -$0.01 | $2.1M | $1.17M | N/A | Details | |||
5/12/16 | Q116 | -$0.12 | -$0.12 | $0.00 | $2.9M | $4.09M | N/A | Details | |||
11/12/15 | Q315 | -$0.16 | N/A | N/A | N/A | N/A | N/A | Details | |||
5/14/15 | Q115 | -$0.20 | -$0.34 | +$0.14 | $1.4M | $4.66M | N/A | Details | |||
3/26/15 | Q414 | -$0.26 | -$0.30 | +$0.04 | $5.7M | $4.3M | N/A | Details | |||
3/11/14 | Q113 | -$0.45 | -$0.66 | +$0.21 | $8.6M | $10.2M | N/A | Details | |||
3/7/13 | Q412 | -$0.28 | N/A | N/A | N/A | N/A | N/A | Details |